Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. we hope you enjoy reading it.

1. The National Medical Commission (NMC) has reportedly not initiated any action against 30 doctors involved in a pharma freebies case. An RTI response reveals that the Department of Pharmaceuticals has not directed action, despite earlier findings of violations by the pharmaceutical company sponsoring lavish trips.
Source: bit.ly/44xs6e4

2. The Indian Pharmacopoeia Commission (IPC) has announced changes to certain monograph titles and synonyms in the upcoming Indian Pharmacopoeia (IP) 2026 which is effective from July 2026. Manufacturers have been advised to assess the impact on existing products and start taking necessary steps to update the label.
Source: bit.ly/4dtuq8p

3. India’s Ministry of Health has reportedly raised concerns that only a small fraction of small and medium-sized pharmaceutical companies have applied to the government for an extension of the timeline to comply with the Revised Good Manufacturing Practices (GMP) under Schedule M and to submit their facility upgradation plans. With the 12th May 2025 deadline approaching, state health secretaries have been asked to coordinate with local manufacturers and ensure timely compliance.
Source: bit.ly/4ka44u3

4. The Government of Odisha has reportedly announced plans to draft a state-wide mental health policy, including early intervention frameworks and counselling centres, to address rising mental health issues particularly among vulnerable groups such as youth and the elderly
Source: bit.ly/44peMIy

5. The European Medicines Agency (EMA) has officially recognized suicidal thoughts as a potential side effect of a medication commonly used to treat male pattern baldness. While the EMA maintains that the benefits of the drug continue to outweigh the risks, it has mandated that all 1 mg packages include a patient card highlighting these risks.
Source: bit.ly/3SgZLBr

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. we hope you enjoy reading it. 

1. The Supreme Court of India has dismissed a review petition against its judgment from October 2023, which refused to recognize the right of same-sex couples to enter into marriages or have civil unions. The review petitions challenged the October ruling as being “manifestly unjust” and inconsistent with constitutional values.
Source: bit.ly/3Cg5BOK

2. India’s Parliamentary Committee, in its fifth report on the Department of Pharmaceuticals’ (DoP) 2024-2025 budget, expressed concern over the unavailability of essential medicines at Jan Aushadhi Kendras (JAKs) under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). The report highlighted the absence of life-saving drugs such as Benzylpenicillin, Atropine, Streptomycin, and medicines for tuberculosis and mental illnesses. It recommended conducting feasibility studies to include these critical drugs in the PMBJP list.
Source: bit.ly/4gN2Tzf

3. The Karnataka State Dental Council (KSDC) has notified that engaging in facial aesthetic treatments and hair transplant procedures constitutes “unethical practice” for dentists. This could result in their disqualification from the dental register. This comes amidst an ongoing case in the Bombay High Court concerning the qualifications of dentists to perform aesthetic procedures.
Source: bit.ly/3Prz7UW

4. The Goa Human Rights Commission (GHRC) has recommended that the state government establish additional rehabilitation homes for mental health patients. The commission has also directed the government to expedite the establishment of such rehabilitation homes and to submit an action report within 90 days. The aim is to improve the care and reintegration of these patients into society.
Source: bit.ly/4jcCT2c

5. The Indian state of Odisha has launched the Odisha Pharmaceutical Development Cell (OPDC) to position itself as a global leader in the pharmaceutical industry. The initiative aims to attract international investments and foster innovation. According to reports, the Odisha Pharmaceutical Policy 2025 will provide investment incentives, R&D support, and skill development frameworks. The state targets investments worth ₹50,000 crores through these initiatives.
Source: bit.ly/3DQx22b